Acutus Medical EBIT per Share
EBIT per Share of Acutus Medical (AFIB) as of Aug 9, 2026.
Get this data via API
Financial Data API
EBIT per Share
-0.00USD
YoY
-99.61%
Last updated:
EBIT per Share of Acutus Medical is 2026 -0.00 USD. EBIT per Share of Acutus Medical was 2025 -0.49 USD. It decreases by -99.61% higher compared to the previous year.
Access this data via the Eulerpool API
Acutus Medical Stock analysis
What does Acutus Medical do? The company Acutus Medical Inc was founded in 2011 and is headquartered in California, USA. The company aims to develop innovative technologies to improve the procedures in the diagnosis and treatment of heart disease. The company employs over 300 employees worldwide and has various locations in the USA and Europe.
Acutus Medical Inc's business model is based on the development and marketing of products to improve the diagnosis and treatment options for heart disease. This includes both electrophysiological products for assessing heartbeats and treatment products for regulating heart rate.
An important division of the company is electrophysiological diagnostics. Products are produced here that measure and record the electrical impulse of the heart. This is done, for example, through catheters that are inserted into the heart and use electromagnetic technologies to create an accurate mapping of the heart's electrical activity. This information can help doctors better understand the condition and function of the heart and make informed decisions regarding treatment.
Another important area of Acutus Medical Inc is the therapy of heart disease. The company offers innovative treatment products that help regulate heart rhythm and treat cardiac arrhythmias. Particularly noteworthy here is the product "AcQMap," which enables the use of electromagnetic technologies for mapping the heart and identifying heart rhythm disorders. This allows doctors to develop more targeted treatment strategies and improve treatment accuracy.
Another important division of Acutus Medical Inc is the research and development of new technologies to improve the diagnosis and therapy of heart disease. The company works closely with doctors and research institutes to drive product and procedure innovation.
Overall, Acutus Medical Inc is an innovative company specializing in the development of technologies to improve the diagnosis and treatment of heart disease. The company operates internationally and offers a wide range of innovative products for electrophysiological diagnostics and therapy of heart disease. Through close collaboration with doctors and research institutes, Acutus Medical succeeds in improving existing procedures and developing new approaches for the treatment of heart disease. Acutus Medical is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Acutus Medical stock
On Eulerpool you can find the complete historical development of EBIT per Share Acutus Medical since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Acutus Medical
All Key Metrics — Acutus Medical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth